Literature DB >> 22407438

Recruitment and retention in an adolescent anorexia nervosa treatment trial.

Lisa Brownstone1, Kristen Anderson, Judy Beenhakker, James Lock, Daniel Le Grange.   

Abstract

OBJECTIVE: To investigate recruitment and retention for a randomized controlled trial (RCT) of adolescent anorexia nervosa (AN), as prior studies suggest that these are significant hurdles to completing meaningful RCTs in this population.
METHOD: Retrospective analyses of recruitment and retention rates were conducted for a multisite RCT of family-based treatment (FBT) versus adolescent-focused therapy (AFT) recruiting adolescents between 12 and 18 years of age with AN.
RESULTS: Adolescent participants were recruited from a variety of both medical and nonmedical sources. Recruitment goals were met in time (October 2004-March 2007). Percent retention rates were high across both treatment types (84% for FBT and 92% for AFT), and these rates did not differ significantly. DISCUSSION: These results reveal that recruitment and retention of adolescent patients with AN to RCTs are feasible in contrast to the experience in adult studies. It is likely that characteristics of our clinical programs make recruitment easier than in other settings, e.g., child and adolescent focused, specialized eating disorders program with an emphasis on outpatient treatment, recognized leaders in the field, and a history of clinical excellence with this population.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22407438      PMCID: PMC3375356          DOI: 10.1002/eat.22010

Source DB:  PubMed          Journal:  Int J Eat Disord        ISSN: 0276-3478            Impact factor:   4.861


  8 in total

1.  Randomized clinical trial comparing family-based treatment with adolescent-focused individual therapy for adolescents with anorexia nervosa.

Authors:  James Lock; Daniel Le Grange; W Stewart Agras; Ann Moye; Susan W Bryson; Booil Jo
Journal:  Arch Gen Psychiatry       Date:  2010-10

2.  A comparison of short- and long-term family therapy for adolescent anorexia nervosa.

Authors:  James Lock; W Stewart Agras; Susan Bryson; Helena C Kraemer
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2005-07       Impact factor: 8.829

3.  Predictors of treatment acceptance and completion in anorexia nervosa: implications for future study designs.

Authors:  Katherine A Halmi; W Stewart Agras; Scott Crow; James Mitchell; G Terence Wilson; Susan W Bryson; Helena C Kraemer
Journal:  Arch Gen Psychiatry       Date:  2005-07

4.  Planning recruitment.

Authors:  W S Agras; G D Marshall; H C Kraemer
Journal:  Circulation       Date:  1982-12       Impact factor: 29.690

5.  A randomized controlled comparison of family-based treatment and supportive psychotherapy for adolescent bulimia nervosa.

Authors:  Daniel le Grange; Ross D Crosby; Paul J Rathouz; Bennett L Leventhal
Journal:  Arch Gen Psychiatry       Date:  2007-09

6.  Recruitment for an adolescent bulimia nervosa treatment study.

Authors:  Kristen Hewell; Renee Rienecke Hoste; Daniel le Grange
Journal:  Int J Eat Disord       Date:  2006-11       Impact factor: 4.861

7.  Clinical effectiveness of treatments for anorexia nervosa in adolescents: randomised controlled trial.

Authors:  Simon G Gowers; Andrew Clark; Chris Roberts; Alison Griffiths; Vanessa Edwards; Claudine Bryan; Nicola Smethurst; Sarah Byford; Barbara Barrett
Journal:  Br J Psychiatry       Date:  2007-11       Impact factor: 9.319

8.  Participant recruitment for an anorexia nervosa treatment study.

Authors:  Christa McDermott; W Stewart Agras; Scott J Crow; Katherine Halmi; James E Mitchell; Susan Bryson
Journal:  Int J Eat Disord       Date:  2004-01       Impact factor: 4.861

  8 in total
  8 in total

1.  Impact of physiologic estrogen replacement on anxiety symptoms, body shape perception, and eating attitudes in adolescent girls with anorexia nervosa: data from a randomized controlled trial.

Authors:  Madhusmita Misra; Debra K Katzman; Nara Mendes Estella; Kamryn T Eddy; Thomas Weigel; Mark A Goldstein; Karen K Miller; Anne Klibanski
Journal:  J Clin Psychiatry       Date:  2013-08       Impact factor: 4.384

2.  Family therapy approaches for anorexia nervosa.

Authors:  Caroline A Fisher; Sonja Skocic; Kathleen A Rutherford; Sarah E Hetrick
Journal:  Cochrane Database Syst Rev       Date:  2019-05-01

3.  Family therapy approaches for anorexia nervosa.

Authors:  Caroline A Fisher; Sonja Skocic; Kathleen A Rutherford; Sarah E Hetrick
Journal:  Cochrane Database Syst Rev       Date:  2018-10-15

4.  One-year outcome and incidence of anorexia nervosa and restrictive eating disorders among adolescent girls treated as out-patients in a family-based setting.

Authors:  Agneta Rosling; Helena Salonen Ros; Ingemar Swenne
Journal:  Ups J Med Sci       Date:  2016-02-26       Impact factor: 2.384

5.  A systematic review of non-randomised evaluations of strategies to improve participant recruitment to randomised controlled trials.

Authors:  Heidi R Gardner; Loai Albarquoni; Adel El Feky; Katie Gillies; Shaun Treweek
Journal:  F1000Res       Date:  2020-02-05

6.  Challenges in recruiting and retaining adolescents with abuse-related posttraumatic stress disorder: lessons learned from a randomized controlled trial.

Authors:  Anna Vogel; Hannah Comtesse; Rita Rosner
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2020-04-16       Impact factor: 3.033

7.  Efficacy, Safety, and Tolerability of Ansofaxine (LY03005) Extended-Release Tablet for Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding, Phase 2 Clinical Trial.

Authors:  Weifeng Mi; Fude Yang; Huafang Li; Xiufeng Xu; Lehua Li; Qingrong Tan; Guoqiang Wang; Kerang Zhang; Feng Tian; Jiong Luo; Jielai Xia; Kai Yuan; Lin Lu; Jiahui Deng; Jingwei Tian; Hongyan Zhang
Journal:  Int J Neuropsychopharmacol       Date:  2022-03-17       Impact factor: 5.176

8.  A piece of a puzzle-Patient and psychologist experiences of the Affect School as additional treatment in a Swedish eating disorder unit.

Authors:  Suzanne Petersson; Ingrid Wåhlin
Journal:  PLoS One       Date:  2022-07-28       Impact factor: 3.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.